Wednesday, September 26, 2012

Driving Learning Engagement with Virtual Learning

Our CEO, Ron Burns, recently had a chance to speak with Jerry Roche, the Editorial director at Elearning! Magazine, for an article he wrote in this month's issue about driving learner engagement through the use of virtual environments, like ProtoSphere.

You can read the article on their website.

Folks at this week's Enterprise Learning Conference are getting a free copy of the magazine and can read more about some of the things we're seeing in this space.

Stop by our booth, #305, and ask us to show you what we're doing with ProtoSphere to help deliver more engaging training.

Thursday, September 20, 2012

ProtonMedia is Headed to ELCE 2012

Our flights are booked and our hotel reservations are made... we're headed to Irvine, CA next week to attend this year's Enterprise Learning! Conference & Expo. We'll be exhibiting in booth #305 and showing off the latest version of ProtoSphere 2.1, specifically its set of features designed for training and learning engagements.

This year's show promises to be a good one. The conference schedule is packed with elearning industry thought leaders planning to talk about the latest technologies and best practices being used to improve learning within the enterprise.

Stop by and say hello if you're out there, and see how ProtoSphere can help you "Imagine, Inspire, & Innovate".

Wednesday, September 19, 2012

ProtonMedia Joins Asia Training Consortium

I'm very pleased to announce today that ProtonMedia and Microsoft have become members of the Asia Training Consortium, a part of the Pan-Asian Clinical Research Association (PACRA). In partnership with Merck and Microsoft, we will be providing our ProtoSphere virtual immersive environment as a means to allow all ATC member organizations a centralized location for the collaboration and delivery of various global training initiatives.

We issued a press release on the news today so I'll turn your attention to that for more information.


Asia Training Consortium Launches Collaborative Cloud Solution

Microsoft and ProtonMedia to Help Speed Industry Drug Development and Time to Market

September 19, 2012

The Asia Training Consortium (ATC), a Merck-sponsored group of pharmaceutical companies and clinical research organizations that was formed in Shanghai in 2011, has added ProtonMedia and  Microsoft Corporation to ATC to offer best-in-class collaborative cloud solutions to the group, as it seeks to pool resources to train clinical research professionals in the Asia Pac region.  Member companies currently include Merck & Co. (MSD), Orchestrall Inc., RPS, PACRA, Covance, Bayer Healthcare, Pfizer, ClinTec International, Edinburgh Napier University, Novartis China, and UL Eduneering. ProtonMedia and Microsoft have now joined as member companies.

 “Merck believes the entire life sciences industry will need to move towards these kinds of collaborative hubs to reduce the cost of drug development and speed the time to market for new medicines,” says John Constantine, Executive Director & Dean, of the Merck Polytechnic Institute. Merck & Co. is a founding member of ATC and has been a leader in the training area.

Andrea McGonigle, the Managing Director for Microsoft Life Sciences added “Microsoft Life Sciences is excited to be joining the ATC at such an important time when we can bring our cloud-based collaboration solutions into partnership with ProtonMedia’s training expertise to skillfully support a host of new research talent both in the Asia region and the entire industry.”

ProtonMedia will provide ProtoSphere®, its innovative training and collaboration solution to ATC members. Operating on Microsoft’s secure cloud, ProtoSphere® will allow ATC companies to connect and collaborate on a variety of global training initiatives. This advanced 3D immersive environment will be the first of its kind deployed cooperatively for the Life Sciences industry.

“We are honored to be participating in this very forward looking program and believe collaborative cloud based hubs will be instrumental in transforming the entire life sciences industry in the years ahead”  says Ron Burns, CEO of ProtonMedia.

ATC was initiated in October 2011 in Shanghai when multiple pharmaceutical companies and CROs convened to address the common issues of training in the Asia Pacific region.
For more information visit:

ProtonMedia is the developer of ProtoSphere®, the #1 Virtual Collaboration Environment for Life Sciences and winner of two consecutive Microsoft Life Sciences Innovation Awards (with Merck in 2010 for ProtoSphere’s use in R&D collaboration and again in 2011 with PPD for ProtoSphere’s use in the clinical space). Featuring seamless integration with Microsoft Lync, SharePoint, Outlook, and Office 365, ProtoSphere® maximizes engagement for distance learning and remote workforce collaboration. For more information, visit:

Tuesday, September 18, 2012

ProtoSphere Tip of the Week #4: Using a Media Board Surface as a Whiteboard

ProtoSphere’s Media Boards offer a variety of functions that allow you to add different types of content to their surfaces, including the ability to annotate over that content. But what if you just want to use one as a whiteboard? Here’s a quick tip on how to clear a Media Board slide so it can serve as a “blank canvas” for your whiteboarding needs...

Zoom in on the Media Board you wish to turn into a whiteboard.

In the Action Bar at the bottom, click on Add Text.

Within the Text Editor window, hit your spacebar to enter a single space character. Then click Submit.

You’ll now have a clean surface to use as your whiteboard. Click the Annotations tab and have at it.


Wednesday, September 12, 2012

Another Industry Award Recognizing PPD and ProtoSphere

I walked into the office this morning to learn of some really exciting news… our friends at PPD have been named to the 2012 InformationWeek 500 for their use of ProtoSphere! We’ve mentioned PPD a number of times in the past, and in fact, this isn’t the first time they’ve been recognized for their innovation. They were named  Best Contract Research Organization and honored for Best Technological Development in Clinical Trials by Scrip Intelligence and won Microsoft’s 2011 Life Sciences Innovation Award. We continue to be very honored that ProtoSphere and our partners are being recognized in this manner. Great job all around!

Here’s what came over the wire this morning:


PPD Named to InformationWeek 500 List of Top Business Technology Innovators

Unique virtual learning platform helps earn third consecutive annual ranking

WILMINGTON, N.C. (September 12, 2012) - Pharmaceutical Product Development, LLC (PPD) today announced it has been named to the 2012 InformationWeek 500, an annual recognition of the most innovative users of business technology in the United States. PPD was selected for its commitment to industry-leading technology solutions, including PPD® 3D, a unique avatar-based virtual learning environment created to train employees on a global scale.

PPD collaborated with ProtonMedia on its ProtoSphere platform to adapt PPD's classroom training programs for the virtual-world environment. The company deployed PPD 3D across global operations to improve the speed, quality and cost-effectiveness of preparing researchers who oversee clinical trials of new medical treatments.

"Our traditional classroom training program was highly acclaimed and effective for on-boarding and preparing clinical research associates," said Mike Wilkinson, PPD's chief information officer and executive vice president. "Yet our traditional model was not sustainable for a globally deployed staff. Our learning and technology team evolved our training program to create a highly engaging, interactive and always-available virtual learning environment. The results have been impressive, and we plan to expand the use of PPD 3D to help our clients develop the critical therapies needed in today's fast-changing health care environment."

Using personalized, culturally appropriate avatars in PPD 3D, clinical research team members and clients interact in highly social, collaborative and visually appealing three-dimensional virtual spaces. PPD 3D provides mobile learning, communities, blogs, wikis, forums, expert directories and social networking capabilities, while bringing two-way engagement to online learning. Users talk, send instant messages, view and interact with presentation and media content, record notes and access the Web - all at the same time, from anywhere.

"The InformationWeek 500 has recognized the most innovative users of business technology for 24 years, and this year's innovations were particularly impressive," said InformationWeek Editor In Chief Rob Preston. "What the editors looked for are unconventional approaches - new technologies, new models, new ways of grabbing business opportunities and solving complex business problems with IT."

In its third consecutive year being named to the InformationWeek 500, PPD ranked in the top 125 of U.S. business technology leaders. InformationWeek 500 rankings spotlight the power of innovation in information technology, rather than simply identifying the biggest IT spenders. The award was presented at a ceremony in Dana Point, Calif., on Sept. 11. For more information, visit

About PPD
PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 12,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit

Except for historical information, all of the statements, expectations and assumptions, including statements, expectations and assumptions about PPD being named to the InformationWeek 500 list, contained in this news release are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based and could cause actual results to differ materially from the forward-looking statements. Other important factors that could cause future results to differ materially include the following: rapid technological advances that make our services less competitive; competition in the outsourcing industry; the ability to control SG&A spending; risks associated with acquisitions and investments; the ability to attract, integrate and retain key personnel, including our chairman and CEO; overall global economic conditions; economic conditions, research and development spending, and outsourcing trends in the pharmaceutical, biotechnology and government-sponsored research sectors; consolidation in the pharmaceutical and biotechnology industries; PPD's ability to win new business; loss, delay or modification of large contracts; higher-than-expected cancellation rates; the rate of conversion of backlog into revenue; actual operating performance; compliance with drug development regulations; and changes in the regulation of the drug development process. PPD assumes no obligation and expressly disclaims any duty to update these forward-looking statements in the future, except as required by applicable law. These forward-looking statements should not be relied upon as representing PPD's estimates or views as of any date subsequent to the date hereof.

Related Posts Plugin for WordPress, Blogger...